Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis

Trends in Neurosciences

Volumn 39, Issue 6, 2016, Pages 366-377

  Baldo, Brian A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Addiction; Bingeing; Hypothalamus; Nucleus accumbens; Prefrontal cortex; opioid receptor

Indexed keywords

MU OPIATE PEPTIDE; OPIATE PEPTIDE; UNCLASSIFIED DRUG; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT;

CORPUS STRIATUM; EXECUTIVE FUNCTION; HUMAN; HYPOTHALAMUS; IMPULSIVENESS; MENTAL DISEASE; MOTIVATION; NONHUMAN; PRECLINICAL STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; PATHOPHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANALGESICS, OPIOID; ANIMALS; HUMANS; HYPOTHALAMUS; MOTIVATION; PREFRONTAL CORTEX; RECEPTORS, OPIOID, MU; SYNAPTIC TRANSMISSION;

EID: 84969498459     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2016.03.004     Document Type: Review

References (105)

1. Smith J.L., et al. Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. Drug Alcohol Depend. 2014, 145:1-33.
2. Jentsch J.D., Pennington Z.T. Reward, interrupted: inhibitory control and its relevance to addictions. Neuropharmacology 2014, 76:479-486.
3. Kaye W.H., et al. Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa?. Biol. Psychiatry 2013, 73:836-842.
4. American Psychiatric Association and DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5 2013, American Psychiatric Association. 5th edn.
5. Agh T., et al. Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review. Eat Weight Disord. 2015, 20:1-12.
6. Gowing L.R., et al. Global statistics on addictive behaviours: 2014 status report. Addiction 2015, 110:904-919.
7. Soyka M., Rosner S. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review. Curr. Drug Abuse Rev. 2008, 1:280-291.
8. Pettinati H.M., et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J. Clin. Psychopharmacol. 2006, 26:610-625.
9. Kim S.W., et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol. Psychiatry 2001, 49:914-921.
10. Yoon G., Kim S.W. Monthly injectable naltrexone for pathological gambling. Am. J. Psychiatry 2013, 170:682-683.
11. Raymond N.C., et al. Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann. Clin. Psychiatry 2010, 22:56-62.
12. Jonas J.M., Gold M.S. Naltrexone treatment of bulimia: clinical and theoretical findings linking eating disorders and substance abuse. Adv. Alcohol Subst. Abuse 1987, 7:29-37.
13. Drewnowski A., et al. Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am. J. Clin. Nutr. 1995, 61:1206-1212.
14. McElroy S.L., et al. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder. Int. J. Eat. Disord. 2013, 46:239-245.
15. Ziauddeen H., et al. Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol. Psychiatry 2013, 18:1287-1293.
16. Helton S.G., Lohoff F.W. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Psychiatry Res. 2015, 230:121-129.
17. Ray L.A., Hutchison K.E. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch. Gen. Psychiatry 2007, 64:1069-1077.
18. Giuliano C., et al. Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 2012, 37:2643-2652.
19. Blasio A., et al. Opioid system in the medial prefrontal cortex mediates binge-like eating. Addict. Biol. 2014, 19:652-662.
20. Will M.J., et al. The amygdala is critical for opioid-mediated binge eating of fat. Neuroreport 2004, 15:1857-1860.
21. Morganstern I., et al. Disturbances in behavior and cortical enkephalin gene expression during the anticipation of ethanol in rats characterized as high drinkers. Alcohol 2012, 46:559-568.
22. Koob G.F., et al. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 1984, 229:481-486.
23. Negus S.S., et al. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 1993, 265:1245-1252.
24. Fields H.L., Margolis E.B. Understanding opioid reward. Trends Neurosci. 2015, 38:217-225.
25. Trigo J.M., et al. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend. 2010, 108:183-194.
26. Berridge K.C. 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol. Behav. 2009, 97:537-550.
27. Ferezou I., et al. Extensive overlap of mu-opioid and nicotinic sensitivity in cortical interneurons. Cereb. Cortex 2007, 17:1948-1957.
28. Martin-Schild S., et al. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 1999, 405:450-471.
29. Taki K., et al. A group of cortical interneurons expressing mu-opioid receptor-like immunoreactivity: a double immunofluorescence study in the rat cerebral cortex. Neuroscience 2000, 98:221-231.
30. Witkowski G., Szulczyk P. Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism. Brain Res. 2006, 1094:92-106.
31. 2+ channel current by mu opioid receptors in prefrontal cortex pyramidal neurons in rats. Acta Neurobiol. Exp. (Wars.) 2008, 68:10-25.
32. Qu C.L., et al. Activation of mu-opioid receptors in the ventrolateral orbital cortex inhibits the GABAergic miniature inhibitory postsynaptic currents in rats. Neurosci. Lett. 2015, 592:64-69.
33. Mitchell J.M., et al. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci. Transl. Med. 2012, 4:116ra6.
34. 11C]carfentanil PET: replication in an independent cohort. Int. J. Neuropsychopharmacol. 2014, 17:2069-2074.
35. Colasanti A., et al. Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol. Psychiatry 2012, 72:371-377.
36. Love T.M., et al. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch. Gen. Psychiatry 2009, 66:1124-1134.
37. Mena J.D., et al. Induction of hyperphagia and carbohydrate intake by mu-opioid receptor stimulation in circumscribed regions of frontal cortex. J. Neurosci. 2011, 31:3249-3260.
38. Selleck R.A., et al. Endogenous opioid signaling in the medial prefrontal cortex is required for the expression of hunger-induced impulsive action. Neuropsychopharmacology 2015, 40:2464-2474.
39. Meule A., Platte P. Facets of impulsivity interactively predict body fat and binge eating in young women. Appetite 2015, 87:352-357.
40. Hege M.A., et al. Attentional impulsivity in binge eating disorder modulates response inhibition performance and frontal brain networks. Int. J. Obes. (Lond.) 2015, 39:353-360.
41. Schag K., et al. Impulsivity in binge eating disorder: food cues elicit increased reward responses and disinhibition. PLoS ONE 2013, 8:e76542.
42. Schag K., et al. Food-related impulsivity in obesity and binge eating disorder - a systematic review. Obes. Rev. 2013, 14:477-495.
43. Schienle A., et al. Binge-eating disorder: reward sensitivity and brain activation to images of food. Biol. Psychiatry 2009, 65:654-661.
44. Lock J., et al. Aberrant brain activation during a response inhibition task in adolescent eating disorder subtypes. Am. J. Psychiatry 2011, 168:55-64.
45. Filbey F.M., et al. Reward circuit function in high BMI individuals with compulsive overeating: similarities with addiction. Neuroimage 2012, 63:1800-1806.
46. Burger K.S., Stice E. Relation of dietary restraint scores to activation of reward-related brain regions in response to food intake, anticipated intake, and food pictures. Neuroimage 2011, 55:233-239.
47. Seo D., et al. Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiatry 2013, 70:727-739.
48. van Holst R.J., et al. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci. Biobehav. Rev. 2010, 34:87-107.
49. Garcia-Garcia I., et al. Neural responses to visual food cues: insights from functional magnetic resonance imaging. Eur. Eat. Disord. Rev. 2013, 21:89-98.
50. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex 2000, 10:318-325.
51. Rolls E.T., Grabenhorst F. The orbitofrontal cortex and beyond: from affect to decision-making. Prog. Neurobiol. 2008, 86:216-244.
52. Bartra O., et al. The valuation system: a coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value. Neuroimage 2013, 76:412-427.
53. Smith D.V., et al. Functional connectivity with ventromedial prefrontal cortex reflects subjective value for social rewards. Soc. Cogn. Affect. Neurosci. 2014, 9:2017-2025.
54. Tang D.W., et al. Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies. Physiol. Behav. 2012, 106:317-324.
55. Goldstone A.P., et al. Fasting biases brain reward systems towards high-calorie foods. Eur. J. Neurosci. 2009, 30:1625-1635.
56. Schur E.A., et al. Activation in brain energy regulation and reward centers by food cues varies with choice of visual stimulus. Int. J. Obes. (Lond.) 2009, 33:653-661.
57. Uher R., et al. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am. J. Psychiatry 2004, 161:1238-1246.
58. Karhunen L.J., et al. Regional cerebral blood flow during exposure to food in obese binge eating women. Psychiatry Res. 2000, 99:29-42.
59. Unterwald E.M., et al. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 1994, 5:1613-1616.
60. Ghitza U.E., et al. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol. Psychiatry 2010, 68:697-703.
61. Gorelick D.A., et al. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology 2008, 200:475-486.
62. Gorelick D.A., et al. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol. Psychiatry 2005, 57:1573-1582.
63. Zubieta J.K., et al. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat. Med. 1996, 2:1225-1229.
64. Olmstead M.C., et al. Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS ONE 2009, 4:e4410.
65. Altamirano L.J., et al. Interaction between family history of alcoholism and locus of control in the opioid regulation of impulsive responding under the influence of alcohol. Alcohol. Clin. Exp. Res. 2011, 35:1905-1914.
66. Mitchell J.M., et al. Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls. Neuropsychopharmacology 2007, 32:439-449.
67. Preuss T.M. Do rats have prefrontal cortex? The Rose-Woolsey-Akert Program reconsidered. J. Cogn. Neurosci. 1995, 7:1-24.
68. Uylings H.B., et al. Do rats have a prefrontal cortex?. Behav. Brain Res. 2003, 146:3-17.
69. Ongur D., Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex 2000, 10:206-219.
70. Theim K.R., et al. Children's descriptions of the foods consumed during loss of control eating episodes. Eat. Behav. 2007, 8:258-265.
71. Mena J.D., et al. Mu-opioid stimulation in rat prefrontal cortex engages hypothalamic orexin/hypocretin-containing neurons, and reveals dissociable roles of nucleus accumbens and hypothalamus in cortically driven feeding. J. Neurosci. 2013, 33:18540-18552.
72. Stanley B.G., et al. Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control. Am. J. Physiol. 1996, 270:R443-R449.
73. Stanley B.G., et al. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res. 1993, 604:304-317.
74. Petrovich G.D., Gallagher M. Control of food consumption by learned cues: a forebrain-hypothalamic network. Physiol. Behav. 2007, 91:397-403.
75. Stratford T.R., et al. Specific changes in food intake elicited by blockade or activation of glutamate receptors in the nucleus accumbens shell. Behav. Brain Res. 1998, 93:43-50.
76. Krause M., et al. A pause in nucleus accumbens neuron firing is required to initiate and maintain feeding. J. Neurosci. 2010, 30:4746-4756.
77. Maldonado-Irizarry C.S., et al. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J. Neurosci. 1995, 15:6779-6788.
78. Stratford T.R., Kelley A.E. GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J. Neurosci. 1997, 17:4434-4440.
79. Roitman M.F., et al. Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output. Neuron 2005, 45:587-597.
80. Roitman M.F., et al. Hedonic and nucleus accumbens neural responses to a natural reward are regulated by aversive conditioning. Learn. Mem. 2010, 17:539-546.
81. Taha S.A., Fields H.L. Inhibitions of nucleus accumbens neurons encode a gating signal for reward-directed behavior. J. Neurosci. 2006, 26:217-222.
82. Taha S.A., Fields H.L. Encoding of palatability and appetitive behaviors by distinct neuronal populations in the nucleus accumbens. J. Neurosci. 2005, 25:1193-1202.
83. Ghazizadeh A., et al. Prefrontal cortex mediates extinction of responding by two distinct neural mechanisms in accumbens shell. J. Neurosci. 2012, 32:726-737.
84. Burghardt P.R., et al. Endogenous opioid mechanisms are implicated in obesity and weight loss in humans. J. Clin. Endocrinol. Metab. 2015, 100:3193-3201.
85. Newman S., et al. Sweetened-fat intake sensitizes gamma-aminobutyric acid-mediated feeding responses elicited from the nucleus accumbens shell. Biol. Psychiatry 2013, 73:843-850.
86. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 2007, 8:171-181.
87. Boutrel B., de Lecea L. Addiction and arousal: the hypocretin connection. Physiol. Behav. 2008, 93:947-951.
88. Mahler S.V., et al. Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat. Neurosci. 2014, 17:1298-1303.
89. Siegel J.M. Narcolepsy: a key role for hypocretins (orexins). Cell 1999, 98:409-412.
90. Mignot E. Sleep, sleep disorders and hypocretin (orexin). Sleep Med. 2004, 5(Suppl. 1):S2-S8.
91. Aston-Jones G., et al. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009, 56(Suppl. 1):112-121.
92. Espana R.A. Hypocretin/orexin involvement in reward and reinforcement. Vitam. Horm. 2012, 89:185-208.
93. Anderson R.I., et al. Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models. Front. Neurosci. 2014, 8:33.
94. Dhaher R., et al. The orexin-1 receptor antagonist SB-334867 reduces alcohol relapse drinking, but not alcohol-seeking, in alcohol-preferring (P) rats. J. Addict. Med. 2010, 4:153-159.
95. Piccoli L., et al. Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology 2012, 37:1999-2011.
96. Pankevich D.E., et al. Caloric restriction experience reprograms stress and orexigenic pathways and promotes binge eating. J. Neurosci. 2010, 30:16399-16407.
97. Alcaraz-Iborra M., et al. Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: pharmacological and molecular evidence of orexin involvement. Behav. Brain Res. 2014, 272:93-99.
98. Sutton E.L. Profile of suvorexant in the management of insomnia. Drug Des. Devel. Ther. 2015, 9:6035-6042.
99. Zhou L., et al. Orexin receptor targets for anti-relapse medication development in drug addiction. Pharmaceuticals (Basel) 2011, 4:804-821.
100. Plaza-Zabala A., et al. The hypocretin/orexin system: implications for drug reward and relapse. Mol. Neurobiol. 2012, 45:424-439.
101. Zheng H., et al. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J. Neurosci. 2007, 27:11075-11082.
102. Leriche M., et al. Presence of pro-opiomelanocortin mRNA in the rat medial prefrontal cortex, nucleus accumbens and ventral tegmental area: studies by RT-PCR and in situ hybridization techniques. Neuropeptides 2007, 41:421-431.
103. Krook-Magnuson E., et al. Ivy and neurogliaform interneurons are a major target of mu-opioid receptor modulation. J. Neurosci. 2011, 31:14861-14870.
104. Marek G.J., Aghajanian G.K. 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation. Neuroscience 1998, 86:485-497.
105. Marek G.J., et al. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 2001, 105:379-392.